When Drinking Water Raises Bigger Questions About Brain Health And Environmental Risk
By Kevin Westerling,
@KevinOnWater
A recent headline caught my attention: “One Type of Drinking Water Linked to up to 62% Higher Parkinson’s Risk”, published by Newsweek. It raised the usual cautions about how such findings are framed — but it also triggered a personal flashback. Years ago, I wrote about how drinking water might intersect with neurodegenerative disease. A quick search of the Water Online archive turned up my 2012 piece, “Could Tap Water Cause Lou Gehrig’s Disease?”. A (somewhat pained) review made two things clear: I was a bit too eager to treat correlation as causation, but my instincts weren’t entirely off.
The Newsweek-covered study surveys major U.S. aquifers and reports that people drawing from “newer” groundwater (recharged within roughly the last 70–75 years) show a higher Parkinson’s risk than those served by older, deeper glacial aquifers, with the strongest associations in carbonate aquifers. In the most pronounced comparison, the difference reached 62% relative to glacial sources. Importantly, the findings are associational, not causal — circumstantial evidence rather than a verdict.
What the study highlights is that the source of drinking water can shape patterns of environmental exposure, even when the specific contaminant isn’t yet clear.
From Correlation To Environmental Questions
That distinction is central to how we interpret environmental risk today. It’s also where my earlier work needed more finesse. What’s changed since then is the scientific landscape: a substantial body of research on cyanobacteria, environmental toxins, and neurodegenerative disease has matured, echoing some concerns I raised back then.
The aquifer study does not identify a specific contaminant responsible for the elevated risk. Instead, it points toward a broader reality researchers have increasingly recognized: groundwater age, aquifer geology, and recharge patterns shape the mix of naturally occurring compounds and human‑introduced contaminants that ultimately enter drinking water systems.
Cyanobacteria And The Expanding Research Landscape
One area that has drawn growing scientific attention is cyanobacteria and the range of toxins they produce. Over the past decade, researchers have increasingly examined whether certain cyanobacterial compounds could play a role in neurodegenerative disease. Among the most discussed is β‑methylamino‑L‑alanine (BMAA), a neurotoxin produced by some cyanobacteria that has been detected in freshwater ecosystems around the world. Studies have found BMAA in lake sediments, aquatic organisms, and other components of the food web, suggesting that exposure pathways may be broader than previously assumed.
Since my 2012 column, harmful algal bloom research has expanded, with utilities, regulators, and researchers devoting far greater attention to cyanobacteria and the toxins they produce in drinking water sources. Early discussions of environmental links to diseases like ALS or Parkinson’s often relied on isolated geographic clusters or limited datasets. Today, researchers bring larger environmental datasets, improved toxin detection methods, and interdisciplinary work spanning epidemiology, toxicology, and water science. The emerging evidence still falls short of proving direct causation, but it does point toward environmental exposure as a plausible piece of a much larger puzzle.
Why It Matters For The Water Sector
That broader context matters for the drinking water community. Harmful algal blooms have become more frequent in many regions due to warming temperatures, nutrient runoff, and shifting hydrology. Utilities already monitor cyanotoxins such as microcystins and cylindrospermopsin because of their well‑established acute health risks. But the possibility that other cyanobacterial compounds could have long‑term neurological implications has prompted researchers to examine how these ecosystems interact with public health.
None of this means the aquifer study has identified the culprit behind Parkinson’s disease. Neurodegenerative conditions are complex and multifactorial, involving genetics, aging, environmental exposures, and lifestyle influences. What studies like this offer instead is a map of where questions should be asked next.
For utilities and regulators, there are three practical takeaways:
- track not just cyanotoxins with acute thresholds but also the presence of cyanobacterial markers that may indicate broader exposure pathways;
- consider groundwater age and aquifer geology as part of source‑water risk profiling; and
- support data integration across public health, hydrology, and water quality to move from association toward testable mechanisms.
Looking back at that 2012 article, I probably leaned too far toward speculation. But the underlying question — whether the chemistry and ecology of our water sources might intersect with neurological health — wasn’t misplaced. If anything, the past decade has shown that the relationship between water and public health is broader and more complex than we once assumed. Today’s research doesn’t offer definitive answers about Parkinson’s, ALS, or other neurodegenerative diseases. What it does offer is a reminder that drinking water systems sit at the intersection of geology, ecology, and human health. As science continues to explore those connections, the water sector will play an important role — not just in treatment and monitoring, but in paying attention to the subtle environmental signals that may shape the next generation of research.